Immunotherapy (PD-1 Inhibitors e.g., Pembrolizumab/Nivolumab)
Treatment for Malignant neoplasm of bone and articular cartilage
Effectiveness
40%
Safety Score
60%
Clinical Trials
20
Participants
1K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
60
DangerousModerateSafe
Treatment Details
0
Immunotherapy (PD-1 Inhibitors e.g., Pembrolizumab/Nivolumab) Outcomes
for Malignant neoplasm of bone and articular cartilage
Efficacy Outcomes
Overall Effectiveness
+40%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov